Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 1,126.50
+11.00 (0.99%)
At close: Jul 31, 2026
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.12 trillion as of July 31, 2026. Its market cap has increased by 12.25% in one year.
Market Cap
1.12T
Enterprise Value
1.22T
Revenue
271.48B
Ranking
n/a
PE Ratio
22.30
Stock Price
1,126.50
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.12T, an increase of 13,614.21%. That is a compound annual growth rate of 22.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.12T | 22.17% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.94T |
| Lupin | 1.10T |
| Dr. Reddy's Laboratories | 955.93B |
| Abbott India | 590.39B |
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |